{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:52:37Z","timestamp":1792183957926,"version":"4.4.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biotechnol"],"DOI":"10.1186\/s12896-025-01033-w","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:45:00Z","timestamp":1758876300000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["In silico screening and in vitro biological evaluation reveal Queuine as a promising MAP4K4 inhibitor for treating pancreatic cancer"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1013-6668","authenticated-orcid":false,"given":"Nigar","family":"Kantarci-Carsibasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00fcnteha","family":"Girgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nursah D.","family":"Fidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugba","family":"Bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Tarbiat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"issue":"3","key":"1033_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10441-019-09344-0","volume":"67","author":"M Serhani","year":"2019","unstructured":"Serhani M, Essaadi H, Kassara K, Boutoulout A. Control by viability in a chemotherapy cancer model. Acta Biotheor. 2019;67(3):177\u2013200.","journal-title":"Acta Biotheor"},{"issue":"10","key":"1033_CR2","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.2174\/1567201818666210203180853","volume":"18","author":"L Hussein","year":"2021","unstructured":"Hussein L, Gouda M, Buttar HS. Pomegranate, its components, and modern deliverable formulations as potential botanicals in the prevention and treatment of various cancers. Curr Drug Deliv. 2021;18(10):1391\u2013405.","journal-title":"Curr Drug Deliv"},{"issue":"1\u20132019","key":"1033_CR3","first-page":"69","volume":"8","author":"NA Al-Harbi","year":"2019","unstructured":"Al-Harbi NA, Awad NS, Alsberi HM, Abdein MA. Apoptosis induction, cell cycle arrest and in vitro anticancer potentiality of convolvulus spicatus and astragalus Vogelii. World J Environ Biosci. 2019;8(1\u20132019):69\u201375.","journal-title":"World J Environ Biosci"},{"issue":"1","key":"1033_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.15586\/qas.v14i1.1016","volume":"14","author":"M Jiang","year":"2022","unstructured":"Jiang M, Zheng S. Geniposide inhibits non-small cell lung cancer cell migration and angiogenesis by regulating PPAR\u03b3\/VEGF-A pathway. Qual Assur Saf Crops Foods. 2022;14(1):46\u201354.","journal-title":"Qual Assur Saf Crops Foods"},{"issue":"3","key":"1033_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"issue":"4","key":"1033_CR6","first-page":"359","volume":"7","author":"DA Eiznhamer","year":"2004","unstructured":"Eiznhamer DA, Xu ZQ. Betulinic acid: a promising anticancer candidate. IDrugs: Invest Drugs J. 2004;7(4):359\u201373.","journal-title":"IDrugs: Invest Drugs J"},{"issue":"6","key":"1033_CR7","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.surg.2014.02.001","volume":"155","author":"M Bockhorn","year":"2014","unstructured":"Bockhorn M, Uzunoglu FG, Adham M, Imrie C, Milicevic M, Sandberg AA, Izbicki JR. Borderline resectable pancreatic cancer: a consensus statement by the international study group of pancreatic surgery (ISGPS). Surgery. 2014;155(6):977\u201388.","journal-title":"Surgery"},{"key":"1033_CR8","doi-asserted-by":"publisher","first-page":"120043","DOI":"10.1016\/j.ijpharm.2020.120043","volume":"592","author":"S Paroha","year":"2021","unstructured":"Paroha S, Verma J, Dubey RD, Dewangan RP, Molugulu N, Bapat RA, Kesharwani P. Recent advances and prospects in gemcitabine drug delivery systems. Int J Pharm. 2021;592:120043.","journal-title":"Int J Pharm"},{"issue":"4","key":"1033_CR9","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1177\/0034355218792900","volume":"62","author":"C Kaya","year":"2019","unstructured":"Kaya C, Chan F, Tansey T, Bezyak J, Aksoy S, Altundag K. Evaluating the world health organization\u2019s international classification of functioning, disability and health framework as a participation model for cancer survivors in Turkey. Rehabilitation Couns Bull. 2019;62(4):222\u201333.","journal-title":"Rehabilitation Couns Bull"},{"key":"1033_CR10","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.phrs.2017.09.014","volume":"128","author":"D Tewari","year":"2018","unstructured":"Tewari D, Nabavi SF, Nabavi SM, Sureda A, Farooqi AA, Atanasov AG, Bishayee A. Targeting activator protein 1 signaling pathway by bioactive natural agents: possible therapeutic strategy for cancer prevention and intervention. Pharmacol Res. 2018;128:366\u201375.","journal-title":"Pharmacol Res"},{"issue":"8","key":"1033_CR11","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/ja.2010.83","volume":"63","author":"ZR Flores-Bustamante","year":"2010","unstructured":"Flores-Bustamante ZR, Rivera-Orduna FN, Mart\u00ednez-C\u00e1rdenas A, Flores-Cotera LB. Microbial paclitaxel: advances and perspectives. J Antibiot. 2010;63(8):460\u20137.","journal-title":"J Antibiot"},{"issue":"9","key":"1033_CR12","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.3390\/nu11092245","volume":"11","author":"TL Livingstone","year":"2019","unstructured":"Livingstone TL, Beasy G, Mills RD, Plumb J, Needs PW, Mithen R, Traka MH. Plant bioactives and the prevention of prostate cancer: evidence from human studies. Nutrients. 2019;11(9):2245.","journal-title":"Nutrients"},{"key":"1033_CR13","doi-asserted-by":"crossref","unstructured":"Hu Y, Xiang X, Zhang Y, Tian Z, Wang L. Aloin promotes oral squamous cell carcinoma cell apoptosis and autophagy through akt\/mtor pathway. Volume 14. Quality assurance and safety of crops & foods; 2022. pp. 58\u201365. 2.","DOI":"10.15586\/qas.v14i2.978"},{"key":"1033_CR14","doi-asserted-by":"publisher","first-page":"109522","DOI":"10.1016\/j.biopha.2019.109522","volume":"121","author":"R Al Alawi","year":"2020","unstructured":"Al Alawi R, Alhamdani MSS, Hoheisel JD, Baqi Y. Antifibrotic and tumor microenvironment modulating effect of date palm fruit (Phoenix dactylifera L.) extracts in pancreatic cancer. Biomed Pharmacother. 2020;121:109522.","journal-title":"Biomed Pharmacother"},{"key":"1033_CR15","doi-asserted-by":"publisher","first-page":"105538","DOI":"10.1016\/j.ultsonch.2021.105538","volume":"73","author":"M Gouda","year":"2021","unstructured":"Gouda M, Bekhit AED, Tang Y, Huang Y, Huang L, He Y, Li X. Recent innovations of ultrasound green technology in herbal phytochemistry: a review. Ultrason Sonochem. 2021;73:105538.","journal-title":"Ultrason Sonochem"},{"issue":"12","key":"1033_CR16","first-page":"31","volume":"11","author":"DM Hikal","year":"2017","unstructured":"Hikal DM, Awad NS, Abdein MA. The anticancer activity of cashew (Anacardium occidentale) and almond (Prunus dulcis) kernels. Adv Environ Biol. 2017;11(12):31\u201341.","journal-title":"Adv Environ Biol"},{"key":"1033_CR17","doi-asserted-by":"crossref","unstructured":"Qin G, Yi S. Genkwanin improves inflammatory injury in rats with septic lung injury by regulating NF-\u03baB signaling pathway. Volume 14. Quality assurance and safety of crops & foods; 2022. pp. 66\u201373. 2.","DOI":"10.15586\/qas.v14i2.991"},{"key":"1033_CR18","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez ML, Estrela JM, Ortega \u00c1. (2013). Natural polyphenols and apoptosis induction in cancer therapy. J Carcinog Mutag S, 6.","DOI":"10.4172\/2157-2518.S6-004"},{"issue":"2","key":"1033_CR19","first-page":"158","volume":"12","author":"I Mikolaskova","year":"2023","unstructured":"Mikolaskova I, Crnogorac-Jurcevic T, Smolkova B, Hunakova L. Nutraceuticals as supportive therapeutic agents in diabetes and pancreatic ductal adenocarcinoma. Syst Rev Biology. 2023;12(2):158.","journal-title":"Syst Rev Biology"},{"issue":"1","key":"1033_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MPA.0000000000000257","volume":"44","author":"Y Li","year":"2015","unstructured":"Li Y, Go VLW, Sarkar FH. The role of nutraceuticals in pancreatic cancer prevention and therapy: targeting cellular signaling, micrornas, and epigenome. Pancreas. 2015;44(1):1\u201310.","journal-title":"Pancreas"},{"key":"1033_CR21","doi-asserted-by":"publisher","first-page":"1051952","DOI":"10.3389\/fphar.2022.1051952","volume":"13","author":"X He","year":"2022","unstructured":"He X, Wang N, Zhang Y, Huang X, Wang Y. The therapeutic potential of natural products for treating pancreatic cancer. Front Pharmacol. 2022;13:1051952.","journal-title":"Front Pharmacol"},{"issue":"10","key":"1033_CR22","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/foods6100092","volume":"6","author":"SJ Hewlings","year":"2017","unstructured":"Hewlings SJ, Kalman DS. Curcumin: a review of its effects on human health. Foods. 2017;6(10):92.","journal-title":"Foods"},{"issue":"1","key":"1033_CR23","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1080\/15384047.2022.2058862","volume":"23","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Kong Y, Jiang M, Kuang L, Wan J, Liu S, Zhang Z. Curcumin activates NLRC4, AIM2, and IFI16 inflammasomes and induces pyroptosis by upregulated ISG3 transcript factor in acute myeloid leukemia cell lines. Cancer Biol Ther. 2022;23(1):328\u201335.","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"1033_CR24","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1080\/10717544.2022.2048133","volume":"29","author":"MW Al-Rabia","year":"2022","unstructured":"Al-Rabia MW, Alhakamy NA, Rizg WY, Alghaith AF, Ahmed OA, Fahmy UA. Boosting Curcumin activity against human prostatic cancer PC3 cells by utilizing Scorpion venom conjugated phytosomes as promising functionalized nanovesicles. Drug Delivery. 2022;29(1):807\u201320.","journal-title":"Drug Delivery"},{"issue":"10","key":"1033_CR25","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.3390\/nu11102376","volume":"11","author":"A Giordano","year":"2019","unstructured":"Giordano A, Tommonaro G. Curcumin and cancer. Nutrients. 2019;11(10):2376.","journal-title":"Nutrients"},{"key":"1033_CR26","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s00424-009-0674-y","volume":"458","author":"E Delpire","year":"2009","unstructured":"Delpire E. The mammalian family of sterile 20p-like protein kinases. Pfl\u00fcgers Archiv-European J Physiol. 2009;458:953\u201367.","journal-title":"Pfl\u00fcgers Archiv-European J Physiol"},{"issue":"7544","key":"1033_CR27","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nature14323","volume":"519","author":"P Vitorino","year":"2015","unstructured":"Vitorino P, Yeung S, Crow A, Bakke J, Smyczek T, West K, Ye W. MAP4K4 regulates integrin-FERM binding to control endothelial cell motility. Nature. 2015;519(7544):425\u201330.","journal-title":"Nature"},{"key":"1033_CR28","doi-asserted-by":"crossref","unstructured":"Tang X, Guilherme A, Chakladar A, Powelka AM, Konda S, Virbasius JV, Czech MP. (2006). An RNA interference-based screen identifies MAP4K4\/NIK as a negative regulator of PPAR\u03b3, adipogenesis, and insulin-responsive hexose transport. Proceedings of the National Academy of Sciences, 103(7), 2087\u20132092.","DOI":"10.1073\/pnas.0507660103"},{"key":"1033_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13578-016-0121-7","volume":"6","author":"X Gao","year":"2016","unstructured":"Gao X, Gao C, Liu G, Hu J. MAP4K4: an emerging therapeutic target in cancer. Cell Biosci. 2016;6:56.","journal-title":"Cell Biosci"},{"issue":"43","key":"1033_CR30","doi-asserted-by":"publisher","first-page":"6153","DOI":"10.1038\/s41388-021-02007-w","volume":"40","author":"SK Singh","year":"2021","unstructured":"Singh SK, Kumar S, Viswakarma N, Principe DR, Das S, Sondarva G, Rana A. MAP4K4 promotes pancreatic tumorigenesis via phosphorylation and activation of mixed lineage kinase 3. Oncogene. 2021;40(43):6153\u201365.","journal-title":"Oncogene"},{"issue":"24","key":"1033_CR31","doi-asserted-by":"publisher","first-page":"8516","DOI":"10.1158\/1078-0432.CCR-04-0885","volume":"10","author":"W Xin","year":"2004","unstructured":"Xin W, Yun KJ, Ricci F, Zahurak M, Qiu W, Su GH, Iacobuzio-Donahue CA. MAP2K4\/MKK4 expression in pancreatic cancer: genetic validation of immunohistochemistry and relationship to disease course. Clin Cancer Res. 2004;10(24):8516\u201320.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1033_CR32","doi-asserted-by":"publisher","first-page":"2166039","DOI":"10.1080\/14756366.2023.2166039","volume":"38","author":"CD Chang","year":"2023","unstructured":"Chang CD, Chao MW, Lee HY, Liu YT, Tu HJ, Lien ST, Pan SL. In Silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer. J Enzyme Inhib Med Chem. 2023;38(1):2166039.","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"21","key":"1033_CR33","doi-asserted-by":"publisher","first-page":"7043","DOI":"10.1158\/1078-0432.CCR-08-0381","volume":"14","author":"JJ Liang","year":"2008","unstructured":"Liang JJ, Wang H, Rashid A, Tan TH, Hwang RF, Hamilton SR, Wang H. Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma. Clin Cancer Res. 2008;14(21):7043\u20139.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"1033_CR34","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1158\/1078-0432.CCR-10-0331","volume":"17","author":"AW Liu","year":"2011","unstructured":"Liu AW, Cai J, Zhao XL, Jiang TH, He TF, Fu HQ, Zhang SH. ShRNA-targeted MAP4K4 inhibits hepatocellular carcinoma growth. Clin Cancer Res. 2011;17(4):710\u201320.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1033_CR35","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/carcin\/bgt371","volume":"35","author":"S Chen","year":"2014","unstructured":"Chen S, Li X, Lu D, Xu Y, Mou W, Wang L, Li N. SOX2 regulates apoptosis through MAP4K4-survivin signaling pathway in human lung cancer cells. Carcinogenesis. 2014;35(3):613\u201323.","journal-title":"Carcinogenesis"},{"issue":"9","key":"1033_CR36","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1369\/0022155415590829","volume":"63","author":"N Yang","year":"2015","unstructured":"Yang N, Wang Y, Hui L, Li X, Jiang X. Silencing SOX2 expression by RNA interference inhibits proliferation, invasion and metastasis, and induces apoptosis through MAP4K4\/JNK signaling pathway in human laryngeal cancer TU212 cells. J Histochem Cytochemistry. 2015;63(9):721\u201333.","journal-title":"J Histochem Cytochemistry"},{"issue":"11","key":"1033_CR37","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1158\/1535-7163.MCT-13-0296","volume":"12","author":"G Zhao","year":"2013","unstructured":"Zhao G, Wang B, Liu Y, Zhang JG, Deng SC, Qin Q, Wang CY. miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4. Mol Cancer Ther. 2013;12(11):2569\u201380.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"1033_CR38","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3892\/mmr.2015.4510","volume":"13","author":"YF Liu","year":"2016","unstructured":"Liu YF, Qu GQ, Lu YM, Kong WM, Liu Y, Chen WX, Liao XH. Silencing of MAP4K4 by short hairpin RNA suppresses proliferation, induces G1 cell cycle arrest and induces apoptosis in gastric cancer cells. Mol Med Rep. 2016;13(1):41\u20138.","journal-title":"Mol Med Rep"},{"key":"1033_CR39","first-page":"956580","volume":"20131","author":"JC Loftus","year":"2013","unstructured":"Loftus JC, Yang Z, Kloss J, Dhruv H, Tran NL, Riggs DL. A novel interaction between Pyk2 and MAP4K4 is integrated with glioma cell migration. J Signal Transduct. 2013;20131:956580.","journal-title":"J Signal Transduct"},{"issue":"10","key":"1033_CR40","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1073\/pnas.0600040103","volume":"103","author":"CS Collins","year":"2006","unstructured":"Collins CS, Hong J, Sapinoso L, Zhou Y, Liu Z, Micklash K, Hampton GM. A small interfering RNA screen for modulators of tumor cell motility identifies MAP4K4 as a promigratory kinase. Proc Natl Acad Sci. 2006;103(10):3775\u201380.","journal-title":"Proc Natl Acad Sci"},{"issue":"36","key":"1033_CR41","doi-asserted-by":"publisher","first-page":"4541","DOI":"10.3748\/wjg.v16.i36.4541","volume":"16","author":"SX Han","year":"2010","unstructured":"Han SX, Zhu Q, Ma JL, Zhao J, Huang C, Jia X, Zhang D. Lowered HGK expression inhibits cell invasion and adhesion in hepatocellular carcinoma cell line HepG2. World J Gastroenterology: WJG. 2010;16(36):4541.","journal-title":"World J Gastroenterology: WJG"},{"key":"1033_CR42","volume-title":"Small-molecule drug Discoverysuite (version 2015\u20133)","author":"Sch\u00f6dinger","year":"2015","unstructured":"Sch\u00f6dinger. Small-molecule drug Discoverysuite (version 2015\u20133). New York, NY: Schr\u00f6dinger, LLC; 2015."},{"key":"1033_CR43","unstructured":"Schr\u00f6dinger 2018. Maestro(version2018\u20134) new York, NY:Schr\u00f6dinger, LLC."},{"key":"1033_CR44","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"G Madhavi Sastry","year":"2013","unstructured":"Madhavi Sastry G, Adzhigirey M, Day T, Annabhimoju R, Sherman W. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des. 2013;27:221\u201334.","journal-title":"J Comput Aided Mol Des"},{"issue":"6","key":"1033_CR45","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1021\/ja00214a001","volume":"110","author":"WL Jorgensen","year":"1988","unstructured":"Jorgensen WL, Tirado-Rives J. The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of Cyclic peptides and crambin. J Am Chem Soc. 1988;110(6):1657\u201366.","journal-title":"J Am Chem Soc"},{"key":"1033_CR46","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","volume":"21","author":"JC Shelley","year":"2007","unstructured":"Shelley JC, Cholleti A, Frye LL, Greenwood JR, Timlin MR, Uchimaya M. Epik: a software program for pK a prediction and protonation state generation for drug-like molecules. J Comput Aided Mol Des. 2007;21:681\u201391.","journal-title":"J Comput Aided Mol Des"},{"key":"1033_CR47","doi-asserted-by":"crossref","unstructured":"Wishart, D. S., Knox, C., Guo, A. C., Shrivastava, S., Hassanali, M., Stothard, P.,\u2026 Woolsey, J. (2006). DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic acids research, 34(suppl_1), D668-D672.","DOI":"10.1093\/nar\/gkj067"},{"key":"1033_CR48","doi-asserted-by":"crossref","unstructured":"Girgin M, Isik S, Kantarci-Carsibasi N. (2023). Proposing novel natural compounds against alzheimer\u2019s disease targeting acetylcholinesterase. PLoS ONE, 18(4), e0284994.","DOI":"10.1371\/journal.pone.0284994"},{"issue":"3","key":"1033_CR49","first-page":"229","volume":"1139","author":"U G\u00fcnd\u00fcz","year":"1992","unstructured":"G\u00fcnd\u00fcz U, Elliott MS, Seubert PH, Houghton JA, Houghton PJ, Trewyn RW, Katze JR. Absence of tRNA-guanine transglycosylase in a human colon adenocarcinoma cell line. Biochim Et Biophys Acta (BBA)-Molecular Basis Disease. 1992;1139(3):229\u201338.","journal-title":"Biochim Et Biophys Acta (BBA)-Molecular Basis Disease"},{"issue":"16","key":"1033_CR50","first-page":"4468","volume":"54","author":"W Baranowski","year":"1994","unstructured":"Baranowski W, Dirheimer G, Jakowicki JA, Keith G. Deficiency of queuine, a highly modified purine base, in transfer RNAs from primary and metastatic ovarian malignant tumors in women. Cancer Res. 1994;54(16):4468\u201371.","journal-title":"Cancer Res"},{"issue":"2","key":"1033_CR51","first-page":"93","volume":"14","author":"U Aytac","year":"1994","unstructured":"Aytac U, G\u00fcnd\u00fcz U. Q-modification of tRNAs in human brain tumors. Cancer Biochem Biophys. 1994;14(2):93\u20138.","journal-title":"Cancer Biochem Biophys"},{"issue":"17","key":"1033_CR52","first-page":"4696","volume":"52","author":"BS Huang","year":"1992","unstructured":"Huang BS, Wu RT, Chien KY. Relationship of the Queuine content of transfer ribonucleic acids to histopathological grading and survival in human lung cancer. Cancer Res. 1992;52(17):4696\u2013700.","journal-title":"Cancer Res"},{"issue":"9","key":"1033_CR53","first-page":"4308","volume":"45","author":"B Emmerich","year":"1985","unstructured":"Emmerich B, Zubrod E, Weber H, Maubach PA, Kersten H, Kersten W. Relationship of Queuine-lacking transfer RNAs to the grade of malignancy in human leukemias and lymphomas. Cancer Res. 1985;45(9):4308\u201314.","journal-title":"Cancer Res"},{"key":"1033_CR54","doi-asserted-by":"crossref","unstructured":"Liu, X., Montissol, S., Uber, A., Ganley, S., Grossestreuer, A. V., Berg, K., \u2026 & Donnino, M. W. (2018). The effects of Thiamine on breast cancer cells. Molecules,23(6), 1464.","DOI":"10.3390\/molecules23061464"},{"key":"1033_CR55","doi-asserted-by":"crossref","unstructured":"Com\u00edn-Anduix, B., Boren, J., Martinez, S., Moro, C., Centelles, J. J., Trebukhina,R., \u2026 Cascante, M. (2001). The effect of Thiamine supplementation on tumor proliferation: a metabolic control analysis study. European Journal of Biochemistry, 268(15), 4177\u20134182.","DOI":"10.1046\/j.1432-1327.2001.02329.x"},{"issue":"2","key":"1033_CR56","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.canlet.2003.08.005","volume":"202","author":"WR Bruce","year":"2003","unstructured":"Bruce WR, Furrer R, Shangari N, O\u2019Brien PJ, Medline A, Wang Y. Marginal dietary Thiamin deficiency induces the formation of colonic aberrant crypt foci (ACF) in rats. Cancer Lett. 2003;202(2):125\u20139.","journal-title":"Cancer Lett"},{"key":"1033_CR57","doi-asserted-by":"crossref","unstructured":"Iimura, Y., Andoh, S., Kawamata, T., Sato, A., Yokoyama, K., Imai, Y., \u2026 & Kuroda, S. (2021). Thiamine deficiency and neurological symptoms in patients with hematological cancer receiving chemotherapy: a retrospective analysis. Journal of Neurosciences in Rural Practice, 12(4), 726.","DOI":"10.1055\/s-0041-1735825"},{"key":"1033_CR58","doi-asserted-by":"publisher","first-page":"17062","DOI":"10.1038\/s41598-017-16940-y","volume":"7","author":"M Akbarzadeh","year":"2017","unstructured":"Akbarzadeh M, Movassaghpour AA, Ghanbari H, Kheirandish M, Fathi Maroufi N, Rahbarghazi R, Nouri M, Samadi N. The potential therapeutic effect of melatonin on human ovarian cancer by inhibition of invasion and migration of cancer stem cells. Sci Rep. 2017;7:17062.","journal-title":"Sci Rep"},{"key":"1033_CR59","doi-asserted-by":"crossref","unstructured":"de Lima Mota, A., Jardim-Perassi, B. V., de Castro, T. B., Colombo, J., Sonehara,N. M., Nishiyama, V. K. G., \u2026 & de Campos Zuccari, D. A. P. (2019). Melatonin modifies tumor hypoxia and metabolism by inhibiting HIF-1\u03b1 and energy metabolic pathway in the in vitro and in vivo models of breast cancer. Melatonin Research, 2(4), 83\u201398.","DOI":"10.32794\/mr11250042"},{"issue":"1","key":"1033_CR60","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1600-079X.2011.00865.x","volume":"51","author":"SY Cho","year":"2011","unstructured":"Cho SY, Lee HJ, Jeong SJ, Lee HJ, Kim HS, Chen CY, Kim SH. Sphingosine kinase 1 pathway is involved in melatonin-induced HIF\u20101\u03b1 inactivation in hypoxic PC\u20103 prostate cancer cells. J Pineal Res. 2011;51(1):87\u201393.","journal-title":"J Pineal Res"},{"key":"1033_CR61","doi-asserted-by":"crossref","unstructured":"Lu, J. J., Fu, L., Tang, Z., Zhang, C., Qin, L., Wang, J., \u2026 Deng, W. (2016). Melatonin inhibits AP-2\u03b2\/hTERT, NF-\u03baB\/COX-2 and Akt\/ERK and activates caspase\/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells. Oncotarget, 7(3), 2985.","DOI":"10.18632\/oncotarget.6407"},{"issue":"1","key":"1033_CR62","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/jpi.12092","volume":"56","author":"R Ordonez","year":"2014","unstructured":"Ordonez R, Carbajo-Pescador S, Prieto\u2010Dominguez N, Garc\u00eda\u2010Palomo A, Gonz\u00e1lez\u2010Gallego J, Mauriz JL. Inhibition of matrix metalloproteinase\u20109 and nuclear factor kappa B contribute to melatonin prevention of motility and invasiveness in H ep G 2 liver cancer cells. J Pineal Res. 2014;56(1):20\u201330.","journal-title":"J Pineal Res"},{"key":"1033_CR63","unstructured":"Jaworek J, Leja-Szpak A. (2014). Melatonin influences pancreatic cancerogenesis."},{"key":"1033_CR64","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10495-005-0810-x","volume":"10","author":"U Wenzel","year":"2005","unstructured":"Wenzel U, Nickel A, Daniel H. \u03b1-lipoic acid induces apoptosis in human colon cancer cells by increasing mitochondrial respiration with a concomitant O 2\u2013.-generation. Apoptosis. 2005;10:359\u201368.","journal-title":"Apoptosis"},{"key":"1033_CR65","doi-asserted-by":"crossref","unstructured":"Dozio, E., Ruscica, M., Passafaro, L., Dogliotti, G., Steffani, L., Pagani, A., \u2026& Magni, P. (2010). The natural antioxidant alpha-lipoic acid induces p27Kip1-dependent cell cycle arrest and apoptosis in MCF-7 human breast cancer cells. European journal of pharmacology, 641(1), 29\u201334.","DOI":"10.1016\/j.ejphar.2010.05.009"},{"issue":"3","key":"1033_CR66","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1124\/jpet.106.110965","volume":"319","author":"J Moungjaroen","year":"2006","unstructured":"Moungjaroen J, Nimmannit U, Callery PS, Wang L, Azad N, Lipipun V, Rojanasakul Y. Reactive oxygen species mediate caspase activation and apoptosis induced by lipoic acid in human lung epithelial cancer cells through Bcl-2 downregulation. J Pharmacol Exp Ther. 2006;319(3):1062\u20139.","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"1033_CR67","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1177\/1534735409352082","volume":"8","author":"BM Berkson","year":"2009","unstructured":"Berkson BM, Rubin DM, Berkson AJ. Revisiting the ALA\/N (\u03b1-Lipoic Acid\/Low-Dose Naltrexone) protocol for people with metastatic and nonmetastatic pancreatic cancer: a report of 3 new cases. Integr Cancer Ther. 2009;8(4):416\u201322.","journal-title":"Integr Cancer Ther"},{"key":"1033_CR68","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2165\/00003495-199754030-00009","volume":"54","author":"S Noble","year":"1997","unstructured":"Noble S, Goa KL. Gemcitabine: a review of its Pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer. Drugs. 1997;54:447\u201372.","journal-title":"Drugs"},{"issue":"1","key":"1033_CR69","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1517\/14796694.1.1.7","volume":"1","author":"L Toschi","year":"2005","unstructured":"Toschi L, Finocchiaro G, Bartolini S, Gioia V, Cappuzzo F. Role of gemcitabine in cancer therapy. Future Oncol. 2005;1(1):7\u201317.","journal-title":"Future Oncol"},{"key":"1033_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00280-016-3003-0","volume":"78","author":"J Ciccolini","year":"2016","unstructured":"Ciccolini J, Serdjebi C, Peters GJ, Giovannetti E. Pharmacokinetics and pharmacogenetics of gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective. Cancer Chemother Pharmacol. 2016;78:1\u201312.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4","key":"1033_CR71","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/jcc.21372","volume":"31","author":"G Rastelli","year":"2010","unstructured":"Rastelli G, Rio AD, Degliesposti G, Sgobba M. Fast and accurate predictions of binding free energies using MM-PBSA and MM\u2010GBSA. J Comput Chem. 2010;31(4):797\u2013810.","journal-title":"J Comput Chem"},{"issue":"D1","key":"1033_CR72","doi-asserted-by":"publisher","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","volume":"51","author":"S Kim","year":"2023","unstructured":"Kim S, Chen J, Cheng T, et al. PubChem 2023 update. Nucleic Acids Res. 2023;51(D1):D1373\u201380.","journal-title":"Nucleic Acids Res"},{"key":"1033_CR73","doi-asserted-by":"crossref","unstructured":"Tetko, I. V., Gasteiger, J., Todeschini, R., Mauri, A., Livingstone, D., Ertl, P.,\u2026 & Prokopenko, V. V. (2005). Virtual computational chemistry laboratory\u2013design and description. Journal of computer-aided molecular design, 19, 453\u2013463.","DOI":"10.1007\/s10822-005-8694-y"},{"issue":"11","key":"1033_CR74","doi-asserted-by":"publisher","first-page":"4959","DOI":"10.1021\/acs.jcim.9b00969","volume":"59","author":"F Cheng","year":"2019","unstructured":"Cheng F, Li W, Zhou Y, Shen J, Wu Z, Liu G, Lee PW, Tang Y. Correction to admetsar: a comprehensive source and free tool for assessment of chemical ADMET properties. J Chem Inf Model. 2019;59(11):4959.","journal-title":"J Chem Inf Model"},{"issue":"12","key":"1033_CR75","doi-asserted-by":"publisher","first-page":"5587","DOI":"10.1007\/s00894-013-2044-0","volume":"19","author":"B Kamaraj","year":"2013","unstructured":"Kamaraj B, Rajendran V, Sethumadhavan R, Purohit R. In-silico screening of cancer associated mutation on PLK1 protein and its structural consequences. J Mol Model. 2013;19(12):5587\u201399.","journal-title":"J Mol Model"},{"issue":"12","key":"1033_CR76","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1103\/PhysRevLett.80.2733","volume":"80","author":"I Bahar","year":"1998","unstructured":"Bahar I, Atilgan AR, Demirel MC, Erman B. Vibrational dynamics of folded proteins: significance of slow and fast motions in relation to function and stability. Phys Rev Lett. 1998;80(12):2733.","journal-title":"Phys Rev Lett"},{"issue":"07","key":"1033_CR77","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1142\/S2737416521500460","volume":"20","author":"N Kantarci-Carsibasi","year":"2021","unstructured":"Kantarci-Carsibasi N. Elucidation of conformational dynamics of MDM2 and alterations induced upon inhibitor binding using elastic network simulations and molecular Docking. J Comput Biophys Chem. 2021;20(07):751\u201363.","journal-title":"J Comput Biophys Chem"},{"key":"1033_CR78","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s00280-014-2386-z","volume":"73","author":"BS Hanberry","year":"2014","unstructured":"Hanberry BS, Berger R, Zastre JA. High-dose vitamin B1 reduces proliferation in cancer cell lines analogous to Dichloroacetate. Cancer Chemother Pharmacol. 2014;73:585\u201394.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1033_CR79","unstructured":"Avigliano L. Vitamine idrosolubili. Alimentazione e Nutrizione Umana. 3rd ed. Il Pensiero Scientifico Ed: Rome, Italy,; 2016. pp. 281\u20138."},{"key":"1033_CR80","doi-asserted-by":"publisher","first-page":"4773","DOI":"10.3390\/ijms25094773","volume":"25","author":"E Azzini","year":"2024","unstructured":"Azzini E, Furini T, Polito A, Scalfi L, Pinto A, Gasperi V, Savini I. On behalf of the SINU nutrition in oncology working group. Vitamin nutritional status in patients with pancreatic cancer: a narrative review. Int J Mol Sci. 2024;25:4773.","journal-title":"Int J Mol Sci"},{"key":"1033_CR81","doi-asserted-by":"crossref","unstructured":"Huanwen W, Zhiyong L, Xiaohua S, Xinyu R, Kai W, Tonghua L. (2009). Intrinsic chemoresistance to Gemcitabine is associated with constitutive and laminin-induced phosphorylation of FAK in pancreatic cancer cell lines. Mol Cancer, Dec 21;8:125.","DOI":"10.1186\/1476-4598-8-125"},{"key":"1033_CR82","first-page":"9474273","volume":"20191","author":"Z Chang","year":"2019","unstructured":"Chang Z, Zhang Y, Liu J, Guan C, Gu X, Yang Z, Liu R. GATA1 promotes gemcitabine resistance in pancreatic cancer through antiapoptotic pathway. J Oncol. 2019;20191:9474273.","journal-title":"J Oncol"},{"issue":"12","key":"1033_CR83","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.3390\/cancers12123628","volume":"12","author":"M Amrutkar","year":"2020","unstructured":"Amrutkar M, Vethe NT, Verbeke CS, Aasrum M, Finstadsveen AV, S\u00e1ntha P, Gladhaug IP. Differential gemcitabine sensitivity in primary human pancreatic cancer cells and paired stellate cells is driven by heterogenous drug uptake and processing. Cancers. 2020;12(12):3628.","journal-title":"Cancers"},{"key":"1033_CR84","doi-asserted-by":"crossref","unstructured":"Singh P, Dhawan S, Singh A, Manhas N, Seboletswe P, Khubone L, Sharma AK. (2024). Exploring Novel Coumarin-Tethered Bis\u2010Triazoles: apoptosis Induction in human pancreatic cancer cells, antimicrobial effects, and molecular modeling investigations. ChemMedChem, e202400297.","DOI":"10.1002\/cmdc.202400297"},{"issue":"5080","key":"1033_CR85","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1126\/science.1411529","volume":"258","author":"RM Nitsch","year":"1992","unstructured":"Nitsch RM, Slack BE, Wurtman RJ, Growdon JH. Release of alzheimer\u2019s amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science. 1992;258(5080):304\u20137.","journal-title":"Science"},{"issue":"18","key":"1033_CR86","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","volume":"31","author":"DD Von Hoff","year":"2013","unstructured":"Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, Seay T, Tjulandin SA, Ma WW, Saleh MN, Harris M, Reni M, Dowden S, Laheru D, Bahary N, Ramanathan RK, Tabernero J, Hidalgo M, Goldstein D, Van Cutsem E, Wei X, Iglesias J, Renschler MF. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med Oct. 2013;31(18):1691\u2013703.","journal-title":"N Engl J Med Oct"},{"issue":"2","key":"1033_CR87","doi-asserted-by":"publisher","first-page":"dju413","DOI":"10.1093\/jnci\/dju413","volume":"107","author":"D Goldstein","year":"2015","unstructured":"Goldstein D, El-Maraghi RH, Hammel P, Heinemann V, Kunzmann V, Sastre J, Von Hoff DD. nab-paclitaxel plus gemcitabine for metastatic pancreatic cancer: long-term survival from a phase III trial. J Natl Cancer Inst. 2015;107(2):dju413.","journal-title":"J Natl Cancer Inst"},{"key":"1033_CR88","doi-asserted-by":"crossref","unstructured":"Calabretta, S., Bielli, P., Passacantilli, I., Pilozzi, E., Fendrich, V., Capurso,G., \u2026 & Sette, C. (2016). Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells. Oncogene, 35(16), 2031\u20132039.","DOI":"10.1038\/onc.2015.270"},{"issue":"19","key":"1033_CR89","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","volume":"364","author":"T Conroy","year":"2011","unstructured":"Conroy T, Desseigne F, Ychou M, Bouch\u00e9 O, Guimbaud R, B\u00e9couarn Y, Ducreux M. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364(19):1817\u201325.","journal-title":"N Engl J Med"},{"key":"1033_CR90","doi-asserted-by":"crossref","unstructured":"Caparello, C., Meijer, L. L., Garajova, I., Falcone, A., Le Large, T. Y., Funel, N.,\u2026 & Giovannetti, E. (2016). FOLFIRINOX and translational studies: towards personalized therapy in pancreatic cancer. World journal of gastroenterology, 22(31), 6987.","DOI":"10.3748\/wjg.v22.i31.6987"},{"key":"1033_CR91","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jare.2021.12.005","volume":"40","author":"C Glorieux","year":"2022","unstructured":"Glorieux C, Xia X, You X, Wang Z, Han Y, Yang J, Noppe G, Meester C, Ling J, Robert A, Zhang H, Li SP, Wang H, Chiao PJ, Zhang L, Li X, Huang P. Cisplatin and gemcitabine exert opposite effects on immunotherapy with PD-1 antibody in K-ras-driven cancer. J Adv Res. 2022;40:109\u201324.","journal-title":"J Adv Res"}],"container-title":["BMC Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-025-01033-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12896-025-01033-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-025-01033-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:02:57Z","timestamp":1758880977000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbiotechnol.biomedcentral.com\/articles\/10.1186\/s12896-025-01033-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1033"],"URL":"https:\/\/doi.org\/10.1186\/s12896-025-01033-w","relation":{},"ISSN":["1472-6750"],"issn-type":[{"value":"1472-6750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"22 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No humans\/animals were used for studies that are the basis of this research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"103"}}